CY1117053T1 - Συνθεση μελιου με l-αλανυλ-l-γλουταμινη - Google Patents

Συνθεση μελιου με l-αλανυλ-l-γλουταμινη

Info

Publication number
CY1117053T1
CY1117053T1 CY20151101156T CY151101156T CY1117053T1 CY 1117053 T1 CY1117053 T1 CY 1117053T1 CY 20151101156 T CY20151101156 T CY 20151101156T CY 151101156 T CY151101156 T CY 151101156T CY 1117053 T1 CY1117053 T1 CY 1117053T1
Authority
CY
Cyprus
Prior art keywords
alanyl
glutamine
honey composition
composition
sleep
Prior art date
Application number
CY20151101156T
Other languages
Greek (el)
English (en)
Inventor
Mike Mcinnes
Original Assignee
Benenox Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benenox Limited filed Critical Benenox Limited
Publication of CY1117053T1 publication Critical patent/CY1117053T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Insects & Arthropods (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
CY20151101156T 2011-05-18 2015-12-17 Συνθεση μελιου με l-αλανυλ-l-γλουταμινη CY1117053T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1108343.3A GB201108343D0 (en) 2011-05-18 2011-05-18 Honey composition
EP12723520.8A EP2709638B1 (en) 2011-05-18 2012-05-16 Honey composition with l-alanyl-l-glutamine

Publications (1)

Publication Number Publication Date
CY1117053T1 true CY1117053T1 (el) 2017-04-05

Family

ID=44260736

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151101156T CY1117053T1 (el) 2011-05-18 2015-12-17 Συνθεση μελιου με l-αλανυλ-l-γλουταμινη

Country Status (20)

Country Link
US (2) US10314879B2 (enExample)
EP (1) EP2709638B1 (enExample)
JP (2) JP6328552B2 (enExample)
KR (1) KR101900904B1 (enExample)
CN (2) CN103747791B (enExample)
AU (1) AU2012257566B2 (enExample)
CA (1) CA2834182C (enExample)
CY (1) CY1117053T1 (enExample)
DK (1) DK2709638T3 (enExample)
ES (1) ES2553655T3 (enExample)
GB (1) GB201108343D0 (enExample)
HR (1) HRP20151320T1 (enExample)
HU (1) HUE028293T2 (enExample)
MX (1) MX337139B (enExample)
PL (1) PL2709638T3 (enExample)
PT (1) PT2709638E (enExample)
RS (1) RS54412B1 (enExample)
SI (1) SI2709638T1 (enExample)
SM (1) SMT201600056B (enExample)
WO (1) WO2012156731A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201108343D0 (en) * 2011-05-18 2011-06-29 Hibernation Honey Ltd Honey composition
US20190175685A1 (en) * 2016-08-01 2019-06-13 Filament Biosolutions Inc. Methods of treating and preventing cancer treatment side effects
HUE057583T2 (hu) * 2016-12-30 2022-05-28 Innobio Corporation Ltd Alanil-glutamin dipeptid bioszintetikus enzimet kódoló gén és alkalmazása
CN113040393A (zh) * 2021-03-31 2021-06-29 杨继辉 一种干预焦虑睡眠障碍的营养配方

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2919059A1 (de) 1979-05-10 1980-11-20 Josef Dipl Chem Dr Rer N Klosa Diaetetisches mittel und verfahren zu seiner herstellung
US4532143A (en) * 1984-06-15 1985-07-30 The J. M. Smucker Company Spreadable honey
US4973491A (en) * 1989-06-06 1990-11-27 Ontario Ministry Of Agriculture And Food Honey product
JP2829793B2 (ja) 1991-01-10 1998-12-02 長谷川香料株式会社 飲食品の蜂蜜様風味改善方法
GB9121467D0 (en) 1991-10-10 1991-11-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
JP3473976B2 (ja) * 1992-10-29 2003-12-08 協和醗酵工業株式会社 アラニルグルタミンの製造法
NZ538405A (en) 2002-08-01 2007-12-21 Aesgen Inc Improved treatment of cancer with glutamine and carbohydrate
JP4595651B2 (ja) * 2005-04-25 2010-12-08 株式会社デンソー 生体センサ、睡眠情報処理方法、及び睡眠情報処理装置
US20100197787A1 (en) * 2005-10-12 2010-08-05 Masako Doi Composition for Prevention of Hypoglycemic Condition
CN101312660B (zh) * 2005-11-23 2013-07-17 可口可乐公司 供体重管理之高效甜味剂以及经彼甜化的组成物
US20100234308A1 (en) 2006-03-23 2010-09-16 Kyowa Hakko Kogyo Co., Ltd. Wake-up remedy
WO2007108530A1 (ja) * 2006-03-23 2007-09-27 Kyowa Hakko Kogyo Co., Ltd. 筋肉疲労改善剤
JP5046364B2 (ja) * 2006-09-15 2012-10-10 パナソニック株式会社 睡眠状況評価システム及びそのプログラム
CN101041008A (zh) 2007-04-28 2007-09-26 王军 三冬丹
EP2177113A1 (en) 2008-10-15 2010-04-21 Nestec S.A. Improved liver glycocen synthesis
JP2010260853A (ja) * 2009-04-08 2010-11-18 Kyowa Hakko Bio Co Ltd アラニルグルタミンを含有する造粒粉末、顆粒または錠剤
CN101999572A (zh) * 2010-11-08 2011-04-06 王福起 助眠蜜及制备方法
GB201108343D0 (en) * 2011-05-18 2011-06-29 Hibernation Honey Ltd Honey composition

Also Published As

Publication number Publication date
CA2834182C (en) 2021-05-18
SMT201600056B (it) 2016-04-29
DK2709638T3 (da) 2015-12-21
KR20140058435A (ko) 2014-05-14
AU2012257566A1 (en) 2013-11-14
CN108159391A (zh) 2018-06-15
EP2709638A1 (en) 2014-03-26
CN103747791B (zh) 2018-01-30
GB201108343D0 (en) 2011-06-29
MX337139B (es) 2016-02-12
HUE028293T2 (en) 2016-12-28
SI2709638T1 (sl) 2016-01-29
MX2013012967A (es) 2014-05-13
JP6336003B2 (ja) 2018-06-06
JP6328552B2 (ja) 2018-05-23
KR101900904B1 (ko) 2018-09-21
HK1196097A1 (en) 2014-12-05
EP2709638B1 (en) 2015-09-30
US20190192612A1 (en) 2019-06-27
AU2012257566B2 (en) 2017-03-02
US20140186457A1 (en) 2014-07-03
JP2014513713A (ja) 2014-06-05
US10314879B2 (en) 2019-06-11
JP2017061488A (ja) 2017-03-30
WO2012156731A1 (en) 2012-11-22
CN103747791A (zh) 2014-04-23
RS54412B1 (sr) 2016-04-28
PL2709638T3 (pl) 2016-03-31
CA2834182A1 (en) 2012-11-22
HRP20151320T1 (hr) 2016-01-15
ES2553655T3 (es) 2015-12-10
PT2709638E (pt) 2016-01-07

Similar Documents

Publication Publication Date Title
CY1124000T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες σε κρυσταλλικη μορφη
CY1124311T1 (el) Παρεμποδιστες dna-pk
CY1124307T1 (el) Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρησεις αυτων
CY1117372T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες και η χρηση τους
CY1123552T1 (el) Θεραπειες συνδυασμου με χρηση μοριων προσδεσης psl και pcrv αντι- pseudomonas
CY1121318T1 (el) Συμπλοκα λιποπρωτεϊνων και παρασκευη και χρησεις αυτων
CY1121150T1 (el) Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας
CY1119123T1 (el) Δις-αρυλοσυζευγμενες αρυλοτριαζολονες και η χρηση τους
CY1118680T1 (el) Φαρμακευτικη συνθεση
CY1119596T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
EA201591166A1 (ru) Ингибиторы аутотаксина
CY1123490T1 (el) Συνθεσεις που προερχονται απο χιτοζανη
ECSP19025350A (es) Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi)
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
PH12013502261A1 (en) Partially saturated tricyclic compounds and methods of making and using same
MX343687B (es) Compuestos sulfonamida tricíclica y métodos para su fabricación y uso.
CY1118859T1 (el) 6-αλκινυλο-πυριδινες ως μιμητες smac
BR112014005110A2 (pt) pirimidinas aneladas substituídas e utilização das mesmas
EA201291034A1 (ru) АПТАМЕРЫ К β-NGF И ИХ ПРИМЕНЕНИЕ ПРИ ЛЕЧЕНИИ B-NGF-ОПОСРЕДОВАННЫХ ЗАБОЛЕВАНИЙ И РАССТРОЙСТВ
CY1120094T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει despr036 eξenδinh-4(1-39)-lys6-nh2 για χρηση στην θεραπευτικη αγωγη μιας νευροεκφυλιστικης ασθενειας
EA201201658A1 (ru) Производные пиперидина и их применение для лечения метаболических нарушений
CY1120204T1 (el) Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο
EA201591406A1 (ru) C-19 модифицированные тритерпеноиды с ингибиторной активностью созревания вич
CY1122998T1 (el) Μεθοδοι και συνθεσεις για την αντιμετωπιση της καταθλιψης χρησιμοποιωντας κυκλοβενζαπρινη
MX349254B (es) Compuestos para el tratamiento del sindrome metabolico.